The University of Chicago Header Logo

Connection

Hans Schreiber to Ovalbumin

Back to Details
This is a "connection" page, showing publications Hans Schreiber has written about Ovalbumin.
Hans Schreiber
Connection Strength
0.027
Ovalbumin
  1. Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer. Cancer Immunol Res. 2013 Aug; 1(2):123-33.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.